You just read:

Daiichi Sankyo's VANFLYTA® Receives Approval in Japan for the Treatment of Relapsed/Refractory FLT3-ITD AML

News provided by

Daiichi Sankyo Company, Limited

18 Jun, 2019, 13:00 BST